Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm.
In cystic fibrosis (CF) high iron concentration in airway secretion plays a pivotal role in bacterial multiplication and biofilm formation as well as in inflammatory response. Burkholderia cenocepacia, an opportunistic facultative pathogen responsible for chronic lung infections and cepacia syndrome, recurrently infects CF patients. Lactoferrin (Lf), an iron binding multifunctional glycoprotein synthesized by exocrine glands and neutrophils, has been found at higher concentration in the airway secretions of infected CF patients than in healthy subjects. Here the influence of milk derivative bovine lactoferrin (bLf), an emerging important regulator of iron and inflammatory homeostasis, on invasiveness of B. cenocepacia iron-modulated biofilm, as well as on inflammatory response by infected CF bronchial (IB3-1) cells, is reported. bLf did not significantly affect invasion efficacy by biofilmforming B. cenocepacia clinical strains. Conversely, the addition of bLf to cell monolayers during infection significantly decreased the pro-inflammatory Interleukin (IL)-1beta and increased the anti-inflammatory IL-11 expression compared to that observed in cells infected in the absence of bLf. The bLf ability to modulate genes expressed following B. cenocepacia infection seems related to its localization to the nucleus of infected IB3-1 cells. These results provide evidence for a role of bLf in the protection of infected CF cells from inflammation-related damage, thus extending the therapeutic potential of this multifunctional natural protein.
Department of Public Health and Infectious Disease, Sapienza University of Rome, Italy.
P
P
Valenti
A
A
Catizone
F
F
Pantanella
A
A
Frioni
T
T
Natalizi
M
M
Tendini
F
F
Berlutti
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000302:isolation & purification / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects* / Q000254:growth & development; D001980:Bronchi / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D057508:Burkholderia cenocepacia / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D002417:Cattle; D002460:Cell Line; D003550:Cystic Fibrosis / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000382:microbiology*; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D017370:Interleukin-11 / Q000378:metabolism; D053583:Interleukin-1beta / Q000378:metabolism; D007501:Iron / Q000378:metabolism*; D007781:Lactoferrin / Q000302:isolation & purification / Q000494:pharmacology*; D008892:Milk / Q000737:chemistry
D000893:Anti-Inflammatory Agents; C508611:IL11 protein, human; D018836:Inflammation Mediators; D017370:Interleukin-11; D053583:Interleukin-1beta; D007501:Iron; D007781:Lactoferrin